Figure 2: Proportion of R&D funding by research/product type and by condition, in 2023 Investment in product development focuses on medicines (drugs and biologics) for both endometriosis and uterine fibroids (25% and 14% of total funding respectively), while diagnostics for PCOS received more funding than drugs (14% vs
Each "unit" mark = 0.01 mL
The short answer is that glutathione can be highly effective, but only if it reaches your cells
Anti-inflammatory reduces inflammation, which can help alleviate skin issues
In autolysosomes, lysosomal hydrolases degrade the contents of autophagosomes, including damaged organelles, misfolded proteins, and other cellular debris
Peripheral effects Via the AMY2 and AMY3 receptors Cagrilintide acts peripherally: Slowing of gastric emptying , stronger than with GLP-1 Suppression of postprandial glucagon , helps control postprandial glycemic spikes Modulation of bone remodeling (via AMY3), a neutral effect, but clinically monitored Synergy with GLP-1 (the mechanistic basis of CagriSema) The main innovation is the complementarity with the GLP-1 pathway : GLP-1 suppresses appetite via the arcuate nucleus of the hypothalamus (POMC neurons, AgRP/NPY inhibition) Amylin suppresses appetite via the area postrema (CGRP-like neurons) Two independent centers, two independent mechanisms